• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心力衰竭患者心脏再同步治疗后左右心室电活动之间的关系可以通过体表电位标测来定量评估。

Improved relationship between left and right ventricular electrical activation after cardiac resynchronization therapy in heart failure patients can be quantified by body surface potential mapping.

机构信息

Faculdade de Medicina, Heart Institute (InCor), Hospital das Clínicas, Universidade de São Paulo, São Paulo, SP, Brazil.

出版信息

Clinics (Sao Paulo). 2013 Jul;68(7):986-91. doi: 10.6061/clinics/2013(07)16.

DOI:10.6061/clinics/2013(07)16
PMID:23917664
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3715027/
Abstract

OBJECTIVES

Few studies have evaluated cardiac electrical activation dynamics after cardiac resynchronization therapy. Although this procedure reduces morbidity and mortality in heart failure patients, many approaches attempting to identify the responders have shown that 30% of patients do not attain clinical or functional improvement. This study sought to quantify and characterize the effect of resynchronization therapy on the ventricular electrical activation of patients using body surface potential mapping, a noninvasive tool.

METHODS

This retrospective study included 91 resynchronization patients with a mean age of 61 years, left ventricle ejection fraction of 28%, mean QRS duration of 182 ms, and functional class III/IV (78%/22%); the patients underwent 87-lead body surface mapping with the resynchronization device on and off. Thirty-six patients were excluded. Body surface isochronal maps produced 87 maximal/mean global ventricular activation times with three regions identified. The regional activation times for right and left ventricles and their inter-regional right-to-left ventricle gradients were calculated from these results and analyzed. The Mann-Whitney U-test and Kruskall-Wallis test were used for comparisons, with the level of significance set at p≤0.05.

RESULTS

During intrinsic rhythms, regional ventricular activation times were significantly different (54.5 ms vs. 95.9 ms in the right and left ventricle regions, respectively). Regarding cardiac resynchronization, the maximal global value was significantly reduced (138 ms to 131 ms), and a downward variation of 19.4% in regional-left and an upward variation of 44.8% in regional-right ventricular activation times resulted in a significantly reduced inter-regional gradient (43.8 ms to 17 ms).

CONCLUSIONS

Body surface potential mapping in resynchronization patients yielded electrical ventricular activation times for two cardiac regions with significantly decreased global and regional-left values but significantly increased regional-right values, thus showing an attenuated inter-regional gradient after the cardiac resynchronization therapy.

摘要

目的

很少有研究评估心脏再同步治疗后的心脏电激动动力学。尽管该手术降低了心力衰竭患者的发病率和死亡率,但许多试图确定应答者的方法表明,30%的患者并未获得临床或功能改善。本研究旨在使用体表电位标测技术(一种非侵入性工具)量化和描述心脏再同步治疗对患者心室电激动的影响。

方法

本回顾性研究纳入了 91 例再同步治疗患者,平均年龄 61 岁,左心室射血分数 28%,平均 QRS 时限 182ms,心功能分级 III/IV 级(78%/22%);患者在启用和停用再同步设备时进行了 87 导联体表标测。排除了 36 例患者。体表等时图产生了 87 个最大/平均全局心室激活时间,并确定了 3 个区域。从这些结果计算并分析了右心室和左心室的区域激活时间及其区域间右至左心室梯度。使用 Mann-Whitney U 检验和 Kruskal-Wallis 检验进行比较,显著性水平设置为 p≤0.05。

结果

在固有节律时,区域心室激活时间差异显著(右心室和左心室区域分别为 54.5ms 和 95.9ms)。关于心脏再同步,最大全局值显著降低(从 138ms 降至 131ms),区域左心室激活时间下降 19.4%,区域右心室激活时间上升 44.8%,导致区域间梯度显著降低(从 43.8ms 降至 17ms)。

结论

再同步患者的体表电位标测产生了两个心脏区域的心室电激动时间,全局和区域左心室值显著降低,但区域右心室值显著升高,因此显示心脏再同步治疗后区域间梯度减弱。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bea/3715027/eec78ed34983/cln-68-07-986-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bea/3715027/bd536059dd5b/cln-68-07-986-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bea/3715027/8bc6e51a1066/cln-68-07-986-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bea/3715027/88ca3f2d0546/cln-68-07-986-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bea/3715027/53b274feb012/cln-68-07-986-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bea/3715027/eec78ed34983/cln-68-07-986-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bea/3715027/bd536059dd5b/cln-68-07-986-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bea/3715027/8bc6e51a1066/cln-68-07-986-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bea/3715027/88ca3f2d0546/cln-68-07-986-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bea/3715027/53b274feb012/cln-68-07-986-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bea/3715027/eec78ed34983/cln-68-07-986-g005.jpg

相似文献

1
Improved relationship between left and right ventricular electrical activation after cardiac resynchronization therapy in heart failure patients can be quantified by body surface potential mapping.心力衰竭患者心脏再同步治疗后左右心室电活动之间的关系可以通过体表电位标测来定量评估。
Clinics (Sao Paulo). 2013 Jul;68(7):986-91. doi: 10.6061/clinics/2013(07)16.
2
Noninvasive electrocardiographic mapping to improve patient selection for cardiac resynchronization therapy: beyond QRS duration and left bundle branch block morphology.非侵入性心电图标测改善心脏再同步治疗的患者选择:超越 QRS 时限和左束支传导阻滞形态。
J Am Coll Cardiol. 2013 Jun 18;61(24):2435-2443. doi: 10.1016/j.jacc.2013.01.093. Epub 2013 Apr 16.
3
Coronary sinus activation patterns in patients with and without left bundle branch block undergoing electroanatomic mapping system-guided cardiac resynchronization therapy device implantation.在接受电解剖标测系统引导下心脏再同步治疗设备植入的有和无左束支传导阻滞患者中的冠状静脉窦激活模式
Heart Rhythm. 2017 Feb;14(2):225-233. doi: 10.1016/j.hrthm.2016.10.025. Epub 2016 Oct 28.
4
Permanent His Bundle Pacing for Cardiac Resynchronization Therapy in Patients With Heart Failure and Right Bundle Branch Block.永久性希氏束起搏用于心力衰竭合并右束支传导阻滞患者的心脏再同步治疗。
Circ Arrhythm Electrophysiol. 2018 Sep;11(9):e006613. doi: 10.1161/CIRCEP.118.006613.
5
Changes in electrical dyssynchrony by body surface mapping predict left ventricular remodeling in patients with cardiac resynchronization therapy.体表标测所显示的电活动不同步变化可预测心脏再同步治疗患者的左心室重构。
Heart Rhythm. 2017 Mar;14(3):392-399. doi: 10.1016/j.hrthm.2016.11.019. Epub 2016 Nov 17.
6
His-Optimized Cardiac Resynchronization Therapy to Maximize Electrical Resynchronization: A Feasibility Study.心脏再同步优化治疗以最大化电学再同步:一项可行性研究。
Circ Arrhythm Electrophysiol. 2019 Feb;12(2):e006934. doi: 10.1161/CIRCEP.118.006934.
7
Ventricular electrical activation in cardiac resynchronization as characterized by body surface potential mapping.
Arq Bras Cardiol. 2007 Mar;88(3):251-7. doi: 10.1590/s0066-782x2007000300001.
8
Body surface mapping using an ECG belt to characterize electrical heterogeneity for different left ventricular pacing sites during cardiac resynchronization: Relationship with acute hemodynamic improvement.使用心电图带进行体表标测以表征心脏再同步治疗期间不同左心室起搏部位的电不均一性:与急性血流动力学改善的关系
Heart Rhythm. 2017 Mar;14(3):385-391. doi: 10.1016/j.hrthm.2016.11.017. Epub 2016 Nov 18.
9
Twenty-millisecond interventricular difference as assessed by body surface potential mapping identifies patients with clinical improvement after implantation of cardiac resynchronization device.通过体表电位标测评估的20毫秒心室间期差异可识别心脏再同步化装置植入后临床症状改善的患者。
Anadolu Kardiyol Derg. 2007 Jul;7 Suppl 1:213-5.
10
Vectorcardiographic QRS area identifies delayed left ventricular lateral wall activation determined by electroanatomic mapping in candidates for cardiac resynchronization therapy.向量心电图 QRS 面积可识别心脏再同步治疗候选者中电解剖标测确定的左心室侧壁延迟激活。
Heart Rhythm. 2016 Jan;13(1):217-25. doi: 10.1016/j.hrthm.2015.07.033. Epub 2015 Jul 29.

引用本文的文献

1
Body Surface Potential Mapping during Ventricular Depolarization in Athletes with Prolonged PQ Interval after Exercise.运动员运动后 PQ 间期延长时心室去极化过程中的体表电位图描记
Arq Bras Cardiol. 2024 Mar 4;121(1):e20230179. doi: 10.36660/abc.20230179. eCollection 2024.
2
Applicability of Body Surface Potential Mapping Through Exercise in Small Animals.小动物运动时体表电位标测的适用性
Arq Bras Cardiol. 2022 Nov;119(5):776-777. doi: 10.36660/abc.20220646.
3
Clinical Utility of Body Surface Potential Mapping in CRT Patients.

本文引用的文献

1
All cause mortality of cardiac resynchronization therapy with implantable cardioverter defibrillator: a meta-analysis of randomized controlled trials.心脏再同步治疗伴植入式心律转复除颤器患者的全因死亡率:一项随机对照试验的荟萃分析。
Int J Cardiol. 2010 Dec 3;145(3):413-7. doi: 10.1016/j.ijcard.2010.05.016. Epub 2010 Jun 12.
2
Value of right ventricular-left ventricular interlead electrical delay to predict reverse remodelling in cardiac resynchronization therapy: the INTER-V pilot study.右心室-左心室心内电延迟对预测心脏再同步治疗中逆重构的价值:INTER-V 先导研究。
Europace. 2010 Jan;12(1):78-83. doi: 10.1093/europace/eup347.
3
体表电位标测在心脏再同步治疗患者中的临床应用
Arrhythm Electrophysiol Rev. 2021 Jul;10(2):113-119. doi: 10.15420/aer.2021.14.
Noncontact mapping of left ventricle during CRT implant.
Pacing Clin Electrophysiol. 2010 Jan;33(1):74-84. doi: 10.1111/j.1540-8159.2009.02578.x. Epub 2009 Oct 10.
4
The European cardiac resynchronization therapy survey.欧洲心脏再同步化治疗调查。
Eur Heart J. 2009 Oct;30(20):2450-60. doi: 10.1093/eurheartj/ehp359. Epub 2009 Aug 31.
5
Cardiac resynchronization therapy in patients with heart failure: systematic review.心力衰竭患者的心脏再同步治疗:系统评价
Sao Paulo Med J. 2009 Jan;127(1):40-5. doi: 10.1590/s1516-31802009000100009.
6
Results of the Predictors of Response to CRT (PROSPECT) trial.心脏再同步化治疗反应预测因子(PROSPECT)试验的结果。
Circulation. 2008 May 20;117(20):2608-16. doi: 10.1161/CIRCULATIONAHA.107.743120. Epub 2008 May 5.
7
The optimized V-V interval determined by interventricular conduction times versus invasive measurement by LVdP/dtMAX.通过心室传导时间确定的优化V-V间期与通过左心室压力最大上升速率(LVdP/dtMAX)进行的有创测量结果对比。
J Cardiovasc Electrophysiol. 2008 Sep;19(9):939-44. doi: 10.1111/j.1540-8167.2008.01160.x. Epub 2008 Apr 9.
8
Electrocardiographic imaging of patients with heart failure with left bundle branch block and response to cardiac resynchronization therapy.左束支传导阻滞心力衰竭患者的心电图成像及对心脏再同步治疗的反应
J Electrocardiol. 2007 Nov-Dec;40(6 Suppl):S174-8. doi: 10.1016/j.jelectrocard.2007.06.017.
9
Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review.左心室收缩功能障碍患者的心脏再同步治疗:一项系统评价。
JAMA. 2007 Jun 13;297(22):2502-14. doi: 10.1001/jama.297.22.2502.
10
Left ventricular lead electrical delay predicts response to cardiac resynchronization therapy.左心室导联电延迟可预测心脏再同步治疗的反应。
Heart Rhythm. 2006 Nov;3(11):1285-92. doi: 10.1016/j.hrthm.2006.07.034. Epub 2006 Aug 10.